Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Cohort Study of Telomere Biology Among Patients With Early Adenocarcinoma of the Lung

NCT02239432 is registered in ClinicalTrials.gov with Meir Medical Center as lead sponsor.

Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02239432 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Cohort Study of Telomere Biology Among Patients With Early Adenocarcinoma of the Lung
Lead sponsor
Meir Medical Center
Phase
Observational
Overall status
Unknown status
Start date
September 30, 2014
Completion date
September 30, 2017
Enrollment
100 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

adenocarcinoma of the lung, adenocarcinoma, bronchiolo-alveolar